Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights

— Arcadia revenues increase 11% year over year driven by 24% growth in Zola^® —

— Arcadia receives 2.7 million shares of stock in ABVE —

— Arcadia eliminates $1M in liabilities —

DALLAS, Aug. 14, 2025 (GLOBE NEWSWIRE) — Arcadia Biosciences, Inc.^® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the second quarter and first half of 2025.

“We are very pleased with our performance for the second quarter of 2025,” said T.J. Schaefer, CEO of Arcadia. “While our total revenues have increased 11% compared to the second quarter of 2024, Zola^® coconut water revenues have grown 24% and once again surpassed the performance of the category. Our gross margins have now exceeded 30% for ten straight quarters, while our underlying operating expenses remain low, even with almost $700,000 in transaction fees this quarter.

“In addition to our strong operating performance, we received 2.7 million shares of stock in Above Food Ingredients Inc. as a partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheat™ assets in the second quarter of 2024, and we continue to pursue repayment of the remaining outstanding balance. We have also completed the exit from our legacy businesses following the agreement with Bioseed Research India, which resulted in the elimination of the remaining $1 million in contingent liabilities, bringing the total to $2 million of liabilities that have been eliminated year-to-date.

“Our pending business combination with Roosevelt Resources continues to move forward,” Schaefer continued. “We recently filed an amendment to the initial Form S-4 registration statement to provide responses to comments received from the SEC and to provide updated financial information through the first quarter of 2025 for both Arcadia Biosciences and Roosevelt Resources.”